U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
116821116821A Multicenter, Open-label, RebiSmartâ„¢ Autoinjector Ease of Use StudyCompletedHas ResultsMultiple SclerosisDevice: RebiSmartâ„¢https://ClinicalTrials.gov/show/NCT01036165
116822116822Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: BF2.649 (pitolisant)https://ClinicalTrials.gov/show/NCT01036139
116823116823Automatic Versus Evaluative Components of Cue ReactivityCompletedNo Results AvailableDrug Dependencehttps://ClinicalTrials.gov/show/NCT01036126
116824116824A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast CancerActive, not recruitingNo Results AvailableMetastatic Breast CancerDrug: EZN-2208https://ClinicalTrials.gov/show/NCT01036113
116825116825Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Panitumumab|Drug: Nab-paclitaxel|Drug: Carboplatin|Drug: 5-Fluorouracil|Drug: Epirubicin|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT01036087
116826116826Reward Processing in Cocaine AddictionCompletedNo Results AvailableDrug Abuse|Cocaine Dependencehttps://ClinicalTrials.gov/show/NCT01036074
116827116827GSK618334 Repeat Dose StudyCompletedNo Results AvailableSubstance Dependence|Alcoholism|Compulsive DisorderDrug: GSK618334 Low Dose|Drug: GSK618334 PET subjects|Drug: GSK618334 Medium Dose|Drug: GSK618334 High Dosehttps://ClinicalTrials.gov/show/NCT01036061
116828116828A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft DiseaseCompletedNo Results AvailableSaphenous Vein Graft DiseaseDevice: drug eluting stent|Device: bare metal stenthttps://ClinicalTrials.gov/show/NCT01036048
116829116829Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy SubjectsEnrolling by invitationNo Results AvailableIncontinenceDrug: Tolterodine|Drug: Pilocarpine|Drug: THVD-201|Drug: THVD-201|Drug: placebo capsulehttps://ClinicalTrials.gov/show/NCT01036035
116830116830Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative ColitisCompletedNo Results AvailableColitis, UlcerativeDrug: GSK1399686https://ClinicalTrials.gov/show/NCT01036022
116831116831A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic MalignanciesActive, not recruitingHas ResultsAcute Leukemia|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Biphenotypic Leukemia|Pre-leukemic Syndromes|Monosomy 7|Bone Marrow Clonal Malformations|Juvenile Myelomonocytic Leukemia|Myelodysplastic Syndromes|Chronic Myelogenous LeukemiaOther: Withdrawal of immunosuppression and donor lymphocyte infusionhttps://ClinicalTrials.gov/show/NCT01036009
116832116832Dopamine Function and Reward Processing In SchizophreniaRecruitingNo Results AvailableSchizophreniahttps://ClinicalTrials.gov/show/NCT01035996
116833116833Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) HeadachesCompletedNo Results AvailableMigraineDrug: Frovatriptan 2.5 mghttps://ClinicalTrials.gov/show/NCT01035983
116834116834Chitosan Dressings to Facilitate Safe Effective Debridement of Chronic Wounds & Minimize Wound Bacterial Re-colonizationTerminatedHas ResultsWound DebridementDevice: HemCon Dressings and HemCon ChitoGauze; chitosan-based.|Device: Gauze and saline dressings.https://ClinicalTrials.gov/show/NCT01035944
116835116835Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Daily Disposable Lens WearersCompletedHas ResultsMyopiaDevice: Nelfilcon A contact lens|Device: Narafilcon A contact lenshttps://ClinicalTrials.gov/show/NCT01035905
116836116836Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetesDrug: MBX-2982|Drug: MBX-2982|Drug: MBX-2982|Drug: Sitagliptin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01035879
116837116837Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa ColonizationCompletedNo Results AvailableCystic Fibrosis|Pseudomonas AeruginosaDrug: Colistinhttps://ClinicalTrials.gov/show/NCT01035853
116838116838Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes PatientsRecruitingNo Results AvailableType 1 Diabetes MellitusDrug: IN-105|Drug: Insulin Lispro Injectionhttps://ClinicalTrials.gov/show/NCT01035801
116839116839Effects of Mindfulness-Based Cognitive-Behavioral Conjoint Therapy (MB-CBCT) on Post-Traumatic Stress Disorder (PTSD) and Relationship FunctionActive, not recruitingNo Results AvailablePTSDBehavioral: Mindfulness Based Cognitive Behavioral Conjoint Therapy for PTSD|Behavioral: Psychoeducation (control)https://ClinicalTrials.gov/show/NCT01035788
116840116840Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?CompletedNo Results AvailableColorectal Cancer|Colorectal PolypsProcedure: Inspection during insertion|Procedure: Inspection during withdrawalhttps://ClinicalTrials.gov/show/NCT01035775
116841116841Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 YearsCompletedNo Results AvailableH1N1 Subtype|Influenza ABiological: GSK Biologicals' Influenza investigational vaccine GSK2340274A|Biological: GSK Biologicals' Influenza investigational vaccine GSK2340273A|Biological: Placebo (saline)https://ClinicalTrials.gov/show/NCT01035749
116842116842Effect of Functional Genetic Polymorphisms on Brain Morphology and FunctionCompletedNo Results AvailableDrug Abusehttps://ClinicalTrials.gov/show/NCT01035723
116843116843Inflammatory Cytokines Associated With Perinatal Brain InjuryCompletedNo Results AvailableInfant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|Cerebral Palsyhttps://ClinicalTrials.gov/show/NCT01035697
116844116844Safety and Efficacy Study of A0001 in Subjects With Friedreich's AtaxiaCompletedNo Results AvailableFriedreich's AtaxiaDrug: alpha-tocopherolquinone (A0001)|Drug: alpha-tocopherolquinone (A0001)|Drug: placebohttps://ClinicalTrials.gov/show/NCT01035671
116845116845Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal AdenocarcinomaTerminatedHas ResultsOvarian Cancer|Fallopian Tube Cancer|Peritoneal CarcinomaDrug: Pazopanib|Drug: Doxilhttps://ClinicalTrials.gov/show/NCT01035658
116846116846First Time in Human Study of Intravenous Interleukin-18 AntibodyCompletedNo Results AvailableBowel Disease, InflammatoryDrug: GSK1070806https://ClinicalTrials.gov/show/NCT01035645
116847116847Study of Smoking AbstinenceCompletedNo Results AvailableSubstance Abuse Disordershttps://ClinicalTrials.gov/show/NCT01035632
116848116848Pediatric Pharmacokinetics And Safety Study Of MoxidectinWithdrawnNo Results AvailableOnchocerciasisDrug: moxidectinhttps://ClinicalTrials.gov/show/NCT01035619
116849116849Training in Goal-directed Attention Regulation for Individuals With Brain InjuryRecruitingNo Results AvailableBrain InjuryBehavioral: training in goal-directed attention regulation|Behavioral: brain health education|Behavioral: computer-assisted training in goal-directed attention regulationhttps://ClinicalTrials.gov/show/NCT01035606
116850116850Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal TransplantationWithdrawnNo Results AvailableGraft Rejection|Kidney TransplantationProcedure: plasmapheresis and IVIG|Drug: recombinant C1 inhibitorhttps://ClinicalTrials.gov/show/NCT01035593

* Görseller ve İçerik tekif hakkına sahip olabilir